Aventure
Financials
Estimates*
EUR | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|
Revenues | <1m | <1m | 1.4m | 1.5m |
% growth | - | 197 % | 71 % | 12 % |
EBITDA | (<1m) | (<1m) | (<1m) | (<1m) |
% EBITDA margin | (342 %) | (95 %) | (27 %) | (34 %) |
Profit | (<1m) | (1.0m) | (<1m) | (<1m) |
% profit margin | (364 %) | (128 %) | (23 %) | (57 %) |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
Total Funding | - |
Recent News about Aventure
EditAventure AB specializes in developing advanced and clinically verified products, concepts, and processes in the functional food and biotechnology sectors. The company focuses on refining raw materials such as berries, cereals, and healthy bacteria to create products with preventive health effects. These products are designed to be both effective and appealing, ensuring regular consumption for maximum health benefits. Aventure AB serves a diverse range of clients, including health-conscious consumers and businesses in the food and biotechnology industries. The company operates in the global health and wellness market, leveraging its deep understanding of human metabolism to create innovative solutions. Aventure AB's business model involves forming multidisciplinary teams to explore market opportunities, often through joint ventures, partnerships, and subsidiary projects. Revenue is generated through the sale of proprietary health products and collaborative ventures.
Keywords: functional food, biotechnology, preventive health, raw materials, human metabolism, joint ventures, partnerships, clinically proven, health benefits, innovative solutions.